about
sameAs
P185
The Prevalence of Mental Disorders Among Children and Adolescents in the Child Welfare System: A Systematic Review and Meta-AnalysisEEG neurofeedback treatments in children with ADHD: an updated meta-analysis of randomized controlled trialsA Bayesian framework systematic review and meta-analysis of anesthetic agents effectiveness/tolerability profile in electroconvulsive therapy for major depressionThe covariation of independent and dependant variables in neurofeedback: a proposal framework to identify cognitive processes and brain activity variables.[The potential role of microbiota in major psychiatric disorders: Mechanisms, preclinical data, gastro-intestinal comorbidities and therapeutic options].[Blood-injection-injury phobia: Physochophysiological and therapeutical specificities].Fasting in mood disorders: neurobiology and effectiveness. A review of the literature.Treatment with anti-toxoplasmic activity (TATA) for toxoplasma positive patients with bipolar disorders or schizophrenia: a cross-sectional study.Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis.[Homosexual parenthood and child development: present data].Innovative mechanisms of action for pharmaceutical cognitive enhancement: A systematic review.[Toxoplasma gondii: a potential role in the genesis of psychiatric disorders].Comparative analysis of anti-toxoplasmic activity of antipsychotic drugs and valproate.The promise of biological markers for treatment response in first-episode psychosis: a systematic review.The "psychomicrobiotic": Targeting microbiota in major psychiatric disorders: A systematic review.Psychiatry has to take care of its image on-screen.Disparities in suicide mortality trends between United States of America and 25 European countries: retrospective analysis of WHO mortality database.(Mis)use of Prescribed Stimulants in the Medical Student Community: Motives and Behaviors: A Population-Based Cross-Sectional Study.Validation of the Medication Adherence Rating Scale in homeless patients with schizophrenia: Results from the French Housing First experience.A double amino-acid change in the HLA-A peptide-binding groove is associated with response to psychotropic treatment in patients with schizophreniaSmoking behavior characteristics of non-selected smokers with childhood attention-deficit/hyperactivity disorder (AD/HD) history: a systematic review and meta-analysis.Antipsychotic drugs: pro-cancer or anti-cancer? A systematic review.Treating patients with schizophrenia deficit with erythropoietin?Nanopsychiatry--the potential role of nanotechnologies in the future of psychiatry: a systematic review.Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis.Ketamine administration in depressive disorders: a systematic review and meta-analysis.A National network of schizophrenia expert centres: An innovative tool to bridge the research-practice gap.Google Trends: Ready for real-time suicide prevention or just a Zeta-Jones effect? An exploratory study.Validation study of the Medication Adherence Rating Scale. Results from the FACE-SZ national dataset.Differential effects of childhood trauma and cannabis use disorders in patients suffering from schizophrenia.Violent behavior and aggression in schizophrenia: Prevalence and risk factors. A multicentric study from three Latin-America countries.Interleukin-1 β-targeted treatment strategies in inflammatory depression: toward personalized care.A structural equation modelling approach to explore the determinants of quality of life in schizophrenia.Potentially inappropriate psychotropic prescription at discharge is associated with lower functioning in the elderly psychiatric inpatients. A cross-sectional study.The World Health Organization (WHO) dataset for guiding suicide prevention policies: A 3-decade French national survey.Mood disorders are associated with a more severe hypovitaminosis D than schizophrenia.Cyborg psychiatry to ensure agency and autonomy in mental disorders. A proposal for neuromodulation therapeutics.Paradoxical severe agitation induced by add-on high-doses quetiapine in schizo-affective disorder.[Treating specific childhood phobia in a single session? A systematic review of the literature].Aspirin for prevention of cardiovascular events in bipolar disorders.
P50
Q26765149-B257DF6B-0373-46D4-B3DD-B868B4E989F0Q26864646-1E5A7BDE-C8EB-446C-8102-310C33F038E7Q28070019-A34175A7-35C5-4E28-9A1E-488C118DC10EQ30806603-17D228DC-4699-42F3-B5F9-E8D0839E975DQ31031435-DF226E18-7633-46A5-AA63-B2BC96611AA0Q33161938-F0904B4B-F102-481B-82C2-9FB945892814Q34035156-1EE04CB5-509C-442D-B06C-ED70D9E5AF06Q34043459-34D31D46-A49E-4554-BA59-100A217A507EQ34043769-33704038-1390-415D-8BAF-02A41AB333E9Q34180761-78F7B57E-0C1B-4EFD-837A-C198969A294FQ34485652-3BF8E7AA-EA6A-4D71-B31C-DAAC6142B2FFQ34644497-43C69ED5-D94F-48DB-80B2-4F81AF3E1723Q34653239-848F3927-D826-428C-A415-B81823914B80Q35369988-C6DDC05E-C3C4-4176-9931-F6586BDBF9E9Q35483270-ECA72C16-67D3-4D99-B153-040167B75CF3Q35702912-4D7BF592-C10C-423E-BE8E-4DE9640F31E7Q36588647-E6298144-04FF-4166-BEEA-D129369A4D16Q36838005-DD581A19-5679-4C2F-B20F-9B67484A14DFQ37185607-AAAC6E7F-7A47-43EE-83E1-3CE859AD7EBDQ37347570-B300E72A-5932-4AF6-ADBA-0601BB165C90Q37405268-AC8D1FD4-9245-4AAF-8F99-E67E6F68F7AEQ38006311-D772F297-8569-46CC-8E72-E4E1105257D9Q38020966-2819DE56-F344-4FE6-B1B3-D5BAF3ED81C0Q38062741-90B249F6-BC1C-4FA1-A849-B4BD2A997631Q38202523-84D02909-9EB3-42D1-86B3-2F79A2577AA1Q38231235-B56A84F0-8C76-49F7-B181-B6B1E054A01EQ38389166-E19430AD-312C-4023-AC3C-026AF25DAAEEQ38411051-21D49A25-ADC2-4181-93D3-4830762B7106Q38435244-A54AEB64-9312-437C-8577-B9F45BB661A5Q38437886-1610D5EB-0ADD-4313-88A4-ADE7572D3E74Q38822560-167DDCA1-B53A-4571-970D-28EB75CB85B3Q38981762-3381B7B6-1241-489C-B7FB-64CCE3C0C404Q39286091-76D71117-07F4-4C4F-9AE5-A5C3737E321AQ39808900-4F22607B-4143-4172-B7F6-376165939E75Q40541043-7D908B70-3FF6-447C-9159-5A047CAB257EQ41705664-9A9F299F-68C8-4435-B8DC-FBAAD43D5A4BQ42068025-CF8B9B56-15D8-41DA-ADF3-D056B0B698A7Q42706540-5825B1CF-3C2B-4473-8DEB-1431A5662352Q43695446-29673EA8-96FB-4D67-830B-3FA0AEDA683CQ43726731-312AC954-086A-4DCD-A12A-20E09EEC664A
P50
description
Frans arts
@nl
French psychiatrist
@en
French psychiatrist
@en-ca
French psychiatrist
@en-gb
dokter asal Perancis
@id
médicu francés
@ast
psiquiatra francés
@es
psychiatre français
@fr
հետազոտող
@hy
طبيب فرنسي
@ar
name
Guillaume Fond
@ast
Guillaume Fond
@ca
Guillaume Fond
@en
Guillaume Fond
@es
Guillaume Fond
@fr
Guillaume Fond
@nl
Guillaume Fond
@sl
type
label
Guillaume Fond
@ast
Guillaume Fond
@ca
Guillaume Fond
@en
Guillaume Fond
@es
Guillaume Fond
@fr
Guillaume Fond
@nl
Guillaume Fond
@sl
prefLabel
Guillaume Fond
@ast
Guillaume Fond
@ca
Guillaume Fond
@en
Guillaume Fond
@es
Guillaume Fond
@fr
Guillaume Fond
@nl
Guillaume Fond
@sl
P214
P269
P106
P1153
36466346300
P1412
P184
P21
P213
0000 0001 4026 9563
P214
P269
P27
P31
P496
0000-0003-3249-2030
P569
1981-09-15T00:00:00Z
P735
P7859
viaf-216408321